1,2-Dibromocyclooctane
|
- $29.8 - $504.15
- Product name: 1,2-Dibromocyclooctane
- CAS: 29974-69-4
- MF: C8H14Br2
- MW: 270
- EINECS:
- MDL Number:MFCD00086566
- Synonyms:1,2-Dibromocyclooctane;Cyclooctane, 1,2-dibromo-
5 prices
Selected condition：
Brand
- American Custom Chemicals Corporation
- Sigma-Aldrich
Package
- 5MG
- 100mg
- 250mg
- 1 unit
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0297458
- Product description1,2-DIBROMO-CYCLOOCTANE 95.00%
- Packaging5MG
- Price$504.15
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product numberS39072
- Product description1,2-DIBROMO-CYCLOOCTANE Aldrich
- Packaging100mg
- Price$29.8
- Updated2024-03-01
- Buy
- ManufacturerSigma-Aldrich
- Product numberS39072
- Product description1,2-DIBROMO-CYCLOOCTANE AldrichCPR
- Packaging1 unit
- Price$32.7
- Updated2026-04-30
- Buy
- ManufacturerSigma-Aldrich
- Product numberS509000
- Product description1,2-DIBROMOCYCLOOCTANE Aldrich
- Packaging250mg
- Price$110
- Updated2024-03-01
- Buy
- ManufacturerSigma-Aldrich
- Product numberS509000
- Product description1,2-DIBROMOCYCLOOCTANE AldrichCPR
- Packaging1 unit
- Price$121
- Updated2026-04-30
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| American Custom Chemicals Corporation | HCH0297458 | 1,2-DIBROMO-CYCLOOCTANE 95.00% | 5MG | $504.15 | 2021-12-16 | Buy |
| Sigma-Aldrich | S39072 | 1,2-DIBROMO-CYCLOOCTANE Aldrich | 100mg | $29.8 | 2024-03-01 | Buy |
| Sigma-Aldrich | S39072 | 1,2-DIBROMO-CYCLOOCTANE AldrichCPR | 1 unit | $32.7 | 2026-04-30 | Buy |
| Sigma-Aldrich | S509000 | 1,2-DIBROMOCYCLOOCTANE Aldrich | 250mg | $110 | 2024-03-01 | Buy |
| Sigma-Aldrich | S509000 | 1,2-DIBROMOCYCLOOCTANE AldrichCPR | 1 unit | $121 | 2026-04-30 | Buy |
Properties
Boiling point :209.47°C (rough estimate)
Safety Information
| Symbol(GHS): |
 
|
|||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Warning | |||||||||||||||||||||
| Hazard statements: |
|
|||||||||||||||||||||
| Precautionary statements: |
|